Mitsubishi UFJ Asset Management Co., Ltd. - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 63 filers reported holding PROQR THRAPEUTICS N V in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management Co., Ltd. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2022$36,000
-88.0%
39,544
+6.6%
0.00%
-100.0%
Q4 2021$300,000
-24.8%
37,113
-22.1%
0.00%
-50.0%
Q3 2021$399,000
+27.5%
47,655
+2.8%
0.00%0.0%
Q2 2021$313,000
+353.6%
46,369
+285.8%
0.00%
+100.0%
Q3 2019$69,000
-28.1%
12,018
+14.1%
0.00%
-50.0%
Q2 2019$96,000
-19.3%
10,535
+23.1%
0.00%0.0%
Q1 2019$119,000
-4.0%
8,556
+22.7%
0.00%
-33.3%
Q4 2018$124,0006,9710.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2022
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$18,010,7836.83%
M28 Capital Management LP 1,910,600$7,069,2206.74%
Opaleye Management Inc. 1,460,000$5,402,0001.88%
Ikarian Capital, LLC 422,625$1,563,7130.38%
Monaco Asset Management SAM 165,000$610,5000.18%
AWM Investment Company, Inc. 166,667$616,6680.09%
FRANKLIN STREET ADVISORS INC /NC 150,000$5550.05%
Atom Investors LP 18,522$68,5310.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$13,414,2280.03%
GSA CAPITAL PARTNERS LLP 21,514$800.01%
View complete list of PROQR THRAPEUTICS N V shareholders